• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6802220
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/18/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that a higher than expected b-hcg ii (bhcg) result was obtained when a single patient sample was tested using vitros bhcg lot 2860 on a vitros 5600 integrated system.The assignable cause for the higher than expected vitros bhcg result could not be determined.As this was a new lot four days prior to the higher than expected result being obtained, there was not sufficient historical quality control results to draw a conclusion of performance prior to the event.However, current qc performance in combination with vitros bhcg lot 2860 is acceptable.A vitros bhcg lot 2860 performance issue is not a likely contributor to the event.Additionally, an ortho service engineer determined that the microwell subsystem including the luminometer, well wash, signal reagent, and dispense profiles were all as expected.There is no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the event.However, an instrument issue at the time of the event cannot be completely ruled out as no diagnostic precision testing was performed.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros bhcg reagent lot 2860.The customer did not provide their pre-analytical sample handling process for either of the samples.Therefore, improper sample processing (sample centrifugation) cannot be ruled out as a contributor to the event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this cannot be confirmed.Email address for contact office in field (b)(4).
 
Event Description
A customer obtained a higher than expected b-hcg ii (bhcg) result when a single patient sample was tested using vitros bhcg lot 2860 on a vitros 5600 integrated system.Vitros bhcg patient sample 1 result of 69.59 miu/ml vs the expected result of <2.39 miu/ml.Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected.The non-reproducible, higher than expected, vitros bhcg result was reported from the laboratory but a corrected report was issued.There was no allegation of actual patient harm as a result of the event.This report corresponds to ortho clinical diagnostics inc (ortho).Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key11536824
MDR Text Key242526714
Report Number3007111389-2021-00039
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeKU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 03/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/07/2021
Device Catalogue Number6802220
Device Lot Number2860
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/22/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/16/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-